eMedicine Specialties > Emergency Medicine > Infectious Diseases

Ascaris Lumbricoides

Author: Aaron Dora-Laskey, MD, Emergency Physician, Physician Management Group, Dayton, Ohio
Coauthor(s): Ugo Anthony Ezenkwele, MD, MPH, Assistant Professor of Emergency Medicine, Department of Emergency Medicine, New York University School of Medicine/Bellevue Hospital Center; Eric L Weiss, MD, DTM&H, Director of Stanford Travel Medicine, Medical Director of Stanford Lifeflight, Assistant Professor, Departments of Emergency Medicine and Infectious Diseases, Stanford University School of Medicine
Contributor Information and Disclosures

Updated: Jul 30, 2009

Introduction

Background

Intestinal nematode infections affect one fourth to one third of the world's population. Of these, the intestinal roundworm Ascaris lumbricoides is the most common. While the vast majority of these cases are asymptomatic, infected persons may present with pulmonary or potentially severe gastrointestinal complaints. Ascariasis predominates in areas of poor sanitation and is associated with malnutrition, iron-deficiency anemia, and impairments of growth and cognition.
 

Adult <EM>Ascaris lumbricoides</EM>.

Adult Ascaris lumbricoides.

Adult <EM>Ascaris lumbricoides</EM>.

Adult Ascaris lumbricoides.



Pathophysiology

A lumbricoides is the largest of the intestinal nematodes affecting humans, measuring 15-35 cm in length in adulthood. Infection begins with the ingestion of embryonated (infective) eggs in feces-contaminated soil or foodstuffs. Once ingested, eggs hatch, usually in the small intestine, releasing small larvae that penetrate the intestinal wall. Larvae migrate to the pulmonary vascular beds and then to the alveoli via the portal veins usually 1-2 weeks after infection, during which time they may cause pulmonary symptoms (eg, cough, wheezing). During the time frame of pulmonary symptoms, eggs are not being shed, and thus diagnosis via stool ovas and parasites is not possible. Eggs are not shed in stool until roughly 40 days after the development of pulmonary symptoms. 

After migrating up the respiratory tract and being swallowed, they mature, copulate, and lay eggs in the intestines. Adult worms may live in the gut for 6-24 months, where they can cause partial or complete bowel obstruction in large numbers, or they can migrate into the appendix, hepatobiliary system, or pancreatic ducts and rarely other organs such as kidneys or brain. From egg ingestion to new egg passage takes approximately 9 weeks, with an additional 3 weeks needed for egg molting before they are capable of infecting a new host.

Life cycle of <EM>Ascaris lumbricoides</EM>.

Life cycle of Ascaris lumbricoides.

Life cycle of <EM>Ascaris lumbricoides</EM>.

Life cycle of Ascaris lumbricoides.

 

Frequency

United States

In the United States, approximately 4 million people are believed to be infected. High-risk groups include international travelers, recent immigrants (especially from Latin America and Asia), refugees, and international adoptees. Ascariasis is indigenous to the rural southeast, where cross-infection by pigs with the nematode Ascaris suum is thought to occur. (Children aged 2-10 years are thought to be more heavily infected in this and all regions.)

International

Worldwide, 1.4 billion people are infected with A lumbricoides, with prevalence among developing countries as low as 4% in Mafia Island, Zanzibar,1 to as high as 90% in some areas of Indonesia. Local practices (eg, termite mound–eating in Kenya2 ) may predispose to ascariasis in some populations. Other risk factors like dog/cat ownership, presence of pets within the house, and a previous history of geophagia have been noted. In some regions, Ascaris infection is thought to contribute significantly to the burden of abdominal surgical emergencies.

Mortality/Morbidity

The rate of complications secondary to ascariasis ranges from 11-67%, with intestinal and biliary tract obstruction representing the most common serious sequelae. Although infection with A lumbricoides is rarely fatal, it is responsible for an estimated 8,000-100,000 deaths annually, mainly in children, usually from bowel obstruction or perforation in cases of high parasite burden. Due to similarities in the means of infection, many individuals infected with Ascaris are also co-infected with other intestinal parasites.

Race

No racial predilection is known. A genetic predisposition has been described in a study of families from Nepal.3  

Sex

Male children are thought to be infected more frequently, owing to a greater propensity to eat soil.

Age

Children, because of their habits (eg, directly or indirectly consuming soil), are more commonly and more heavily infected than adults. Neonates may be infected by transplacental infection. Frequently, families may be infected and reinfected in group fashion due to shared food and water sources as well as hygiene practices.

Clinical

History

Most patients are asymptomatic. When symptoms occur, they are divided into 2 categories: early (larval migration) and late (mechanical effects).

  • In the early phase (4-16 d after egg ingestion), respiratory symptoms result from the migration of larvae through the lungs. Classically, these symptoms occur in the setting of eosinophilic pneumonia (Löffler syndrome).
    • Fever
    • Nonproductive cough
    • Dyspnea
    • Wheezing
  • In the late phase (6-8 wk after egg ingestion), gastrointestinal symptoms may occur and are more typically related to the mechanical effects of high parasite loads.
    • Passage of worms (from mouth, nares, anus)
    • Diffuse or epigastric abdominal pain
    • Nausea, vomiting
    • Pharyngeal globus, "tingling throat"
    • Frequent throat clearing, dry cough
    • Complications - Biliary and intestinal obstruction, appendicitis, pancreatitis

Physical

  • General
    • Fever
    • Jaundice (in biliary obstruction)
    • Cachexia (due to malnutrition)  
    • Pallor (anemia)
    • Urticaria (early infection)
  • Pulmonary
    • Wheezing
    • Rales
    • Diminished breath sounds
  • Abdominal
    • Abdominal tenderness, which may be diffuse (in obstructive infections), or localized to the right lower (appendicitis) or right upper quadrant (hepatobiliary infections)
    • Peritoneal signs in cases of bowel perforation
    • Obstructive symptoms (nausea/vomiting/constipation/distention)
  • Migrating larvae may transmit other organisms, causing bacterial pneumonia or cholangitis. Rare cases of airway obstruction have also been reported. Other much less common presentations include lacrimal drainage obstruction,4 small bowel intussusception,5 acute interstitial nephritis,6 and encephalopathy.7

Causes

Symptoms are typically associated with early larval migration, heavy intestinal burdens of adult worms, or aberrant worm migration. Worm migration may be stimulated by anesthetic agents, fever, or subtherapeutic anthelmintic treatment, or by use of certain anthelmintics (eg, pyrantel pamoate).

More on Ascaris Lumbricoides

Overview: Ascaris Lumbricoides
Differential Diagnoses & Workup: Ascaris Lumbricoides
Treatment & Medication: Ascaris Lumbricoides
Follow-up: Ascaris Lumbricoides
Multimedia: Ascaris Lumbricoides
References

References

  1. Albonico M, Ramsan M, Wright V, et al. Soil-transmitted nematode infections and mebendazole treatment in Mafia Island schoolchildren. Ann Trop Med Parasitol. Oct 2002;96(7):717-26. [Medline].

  2. Luoba AI, Wenzel Geissler P, Estambale B, et al. Earth-eating and reinfection with intestinal helminths among pregnant and lactating women in western Kenya. Trop Med Int Health. Mar 2005;10(3):220-7. [Medline].

  3. Williams-Blangero S, Subedi J, Upadhayay RP, et al. Genetic analysis of susceptibility to infection with Ascaris lumbricoides. Am J Trop Med Hyg. Jun 1999;60(6):921-6. [Medline].

  4. Mwanza JC. Lacrimal drainage obstruction by Ascaris lumbricoides. Bull Soc Belge Ophtalmol. 2004;71-3. [Medline].

  5. Karatepe O, Tukenmez M, Salmashogul A, et al. Ascaris as a leading point for small-bowel intussusception in an adult: a rare cause of intussusception. Am J Emerg Med. Mar 1 2008;26(3):381.e3-381.e4.

  6. Jung O, Ditting T, Grone HJ, Geiger H, Hauser IA. Acute interstitial nephritis in a case of Ascaris lumbricoides infection. Nephrol Dial Transplant. Jun 2004;19(6):1625-8. [Medline].

  7. Selimoglu MA, Ozturk CF, Ertekin V. A rare manifestation of ascariasis: encephalopathy. J Emerg Med. Jan 2005;28(1):87-8. [Medline].

  8. Arya PK, Kukreti R, Arya M, Gupta SN. Magnetic resonace appearance of gall bladder ascariasis. Indian J Med Sci. May 2005;59(5):208-10. [Medline].

  9. Xiao SH, Hui-Ming W, Tanner M, Utzinger J, Chong W. Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop. Apr 2005;94(1):1-14. [Medline].

  10. Steinmann P, Zhou XN, Du ZW, Jiang JY, Xiao SH, Wu ZX, et al. Tribendimidine and Albendazole for Treating Soil-Transmitted Helminths, Strongyloides stercoralis and Taenia spp.: Open-Label Randomized Trial. PLoS Negl Trop Dis. 2008;2(10):e322. [Medline].

  11. Bell DR. Soil transmitted helminths. In: Lecture Notes on Tropical Medicine. Boston: Blackwell Science; 1985:167-192.

  12. Cappello M, Hotez PJ. Intestinal Nematodes. Philadelphia: Churchill-Livingstone; 2003:1331-1333.

  13. Freedman DO. Intestinal nematodes. In: Gorbach, ed. Infectious Diseases. Philadelphia: WB Saunders; 1992:2003-2008.

  14. Gilles HM. Intestinal nematode infections. In: GT Strickland, ed. Hunter's Tropical Medicine. Philadelphia: WB Saunders; 1984:620-644.

  15. Liu LX, Weller PF. Antiparasitic drugs. N Engl J Med. May 2 1996;334(18):1178-84. [Medline].

  16. Muennig P, Pallin D, Sell RL, Chan MS. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med. Mar 11 1999;340(10):773-9. [Medline].

  17. Talaat KR, Nutman TB. Parasitic Diseases. In: Mason, ed. Murray & Nadel's Textbook of Respiratory Medicine. Philadelphia: Saunders; 2003:1090-1092.

  18. Urbani C, Albonico M. Anthelminthic drug safety and drug administration in the control of soil-transmitted helminthiasis in community campaigns. Acta Trop. May 2003;86(2-3):215-21. [Medline].

Further Reading

Keywords

Ascaris lumbricoides, A lumbricoides, ascariasis, roundworm, intestinal parasite, roundworm treatment, roundworm symptoms, intestinal roundworm, human parasite, nematode infection, malnutrition, iron-deficiency anemia, bowel obstruction, Ascaris suum, eosinophilic pneumonia, Löffler syndrome

Contributor Information and Disclosures

Author

Aaron Dora-Laskey, MD, Emergency Physician, Physician Management Group, Dayton, Ohio
Aaron Dora-Laskey, MD is a member of the following medical societies: American Academy of Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Ugo Anthony Ezenkwele, MD, MPH, Assistant Professor of Emergency Medicine, Department of Emergency Medicine, New York University School of Medicine/Bellevue Hospital Center
Ugo Anthony Ezenkwele, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, National Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Eric L Weiss, MD, DTM&H, Director of Stanford Travel Medicine, Medical Director of Stanford Lifeflight, Assistant Professor, Departments of Emergency Medicine and Infectious Diseases, Stanford University School of Medicine
Eric L Weiss, MD, DTM&H is a member of the following medical societies: American College of Emergency Physicians, American College of Occupational and Environmental Medicine, American Medical Association, American Society of Tropical Medicine and Hygiene, Physicians for Social Responsibility, Southeastern Surgical Congress, Southern Association for Oncology, Southern Clinical Neurological Society, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Mark Louden, MD, FACEP, Assistant Medical Director, Emergency Department, Duke Raleigh Hospital
Mark Louden, MD, FACEP is a member of the following medical societies: American Academy of Emergency Medicine and American College of Emergency Physicians
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Jon Mark Hirshon, MD, MPH, Associate Professor, Department of Emergency Medicine, University of Maryland School of Medicine
Jon Mark Hirshon, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Public Health Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: WebMD Salary Employment

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.